Evidence map›Paper›PMID 21250785›Full record

ArticleFree radical research2011

Breast fine-needle aspiration malondialdehyde deoxyguanosine adduct in breast cancer.

Marco Peluso, Armelle Munnia, Gabriella G Risso, Sandra Catarzi, Sara Piro, Marcello Ceppi, Roger W Giese, Beniamino Brancato

Abstract read
In one paragraph

Article in Free radical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Therapeutic Role ofBreast cancer (Dove Medical Press) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Aberrant methylation of hypermethylated-in-cancer-1 and exocyclic DNA adducts in tobacco smokers.Toxicological sciences : an official journal of the Society of Toxicology · 2014
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marco PelusoCancer Risk Factor Branch, ISPO-Cancer Prevention and Research Institute, Florence, Italy. m.peluso@ispo.toscana.it
Armelle Munnia
Gabriella G Risso
Sandra Catarzi
Sara Piro
Marcello Ceppi
Roger W Giese
Beniamino Brancato
Piedmont Reference Center for Epidemiology and Cancer Prevention · ITPrevention Institute · USNortheastern University · US

Funding

Research Experiences and Training Coordination CoreP42ES017198 · NIEHS · NORTHEASTERN UNIVERSITY · PI ALSHAWABKEH, AKRAM N · 2010 to 2024
$38.6M
NIEHS NIH HHS P42 ES017198NIEHS NIH HHS P42ES017198
6 · The paper itself

Abstract

This study has analysed the generation of 3-(2-deoxy-β-D-erythro-pentafuranosyl)pyrimido[1,2-α]purin-10(3H)-one deoxyguanosine adduct [M₁dG], a biomarker of oxidative stress and lipid peroxidation, in breast fine-needle aspirate samples of 22 patients with breast cancer, at different clinical stages, in respect to 13 controls. The multivariate analysis show that M(1)dG adduct was higher in cases than in controls (Mean Ratio (MR) = 5.26, 95% CI = 3.16-8.77). Increased M₁dG was observed in women with a tumour grade 3 and a pathological diameter 2 (MR = 7.61, 95% CI = 3.91-14.80 and MR = 5.75, 95% CI = 3.13-10.59, respectively). A trend with increasing tumour grade and pathological diameter was present (MR = 1.98, 95% CI = 1.57-2.50 and MR = 2.44, 95% CI = 1.71-3.48, respectively). Not significant effects of age and smoking habit were found (MR = 1.58, 95% CI = 0.92-2.72 and MR = 1.68, 95% CI 0.88-3.20, respectively). An increment over the background frequency of M₁dG can contribute to breast cancer development. Increasing severity of breast tumour can influence DNA damage level.

Indexed as

AgedAge FactorsAnimalsBiomarkers, TumorBiopsy, Fine-NeedleBreast NeoplasmsCase-Control StudiesCattleDeoxyguanosineDNADNA AdductsDNA DamageFemaleHumansItalyLipid Peroxidation3-(2'-deoxy-beta-D-erythro-pentofuranosyl)pyrimido(1,2-alpha)purin-10(3H)-oneBiomarkers, Tumorcalf thymus DNADeoxyguanosineDNADNA AdductsMalondialdehydePurine Nucleosides

Identifiers

PMID21250785
PMCPMC3315697
OpenAlexW2006035131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.